open access

Vol 78, No 7 (2007)
ARTICLES
Get Citation

The evaluation of selected indices of apoptosis in placentas from pregnancies complicated by fetal growth restriction

Agata Karowicz-Bilińska, Anita Szczerba, Urszula Kowalska-Koprek, Agnieszka Nawrocka-Kunecka
Ginekol Pol 2007;78(7).

open access

Vol 78, No 7 (2007)
ARTICLES

Abstract

Background: Fetal growth restriction is related to a high rate of prematurity and mortality. In cases of unknown origin utero-placental circulation changes are the main factor which is due to the changes in blood vessels. The understanding of the mechanism may help in further prevention of FGR. Material and methods: The expression of bcl-2 and bax in normal pregnancies and complicated by FGR were compared. The study was conducted in 2005-2006 at The Medical University of Lodz – HRP Unit and The Kopernik Hospital – Lodz. Bcl-2 and bax were estimated using an immunohistochemical method. Bcl-2 was estimated in trophoblast, bax in decidua and trophoblast. Results: In a study group the mean value of bcl-2 in trophoblast was 37,04+/-10,51, in a control group the mean value was 65,74+/-6,97. The estimation of bax was done in trophoblast and decidua separately. In the group of FGR mean value of bax expression in trophoblast was 45,35+/-10,5. In decidua the mean bax expression value was 24,11+/-7,3. In controls in trophoblast the mean value was 12,53+/-7,54, in decidua the mean expression of bax was 6,63+/-2,24. Conclusion: 1. Apoptosis in trophoblast is lower in normal pregnancy than in FGR. 2. Increased expression of pro-apoptotic proteins in placenta might be one of the reason for FGR development.

Abstract

Background: Fetal growth restriction is related to a high rate of prematurity and mortality. In cases of unknown origin utero-placental circulation changes are the main factor which is due to the changes in blood vessels. The understanding of the mechanism may help in further prevention of FGR. Material and methods: The expression of bcl-2 and bax in normal pregnancies and complicated by FGR were compared. The study was conducted in 2005-2006 at The Medical University of Lodz – HRP Unit and The Kopernik Hospital – Lodz. Bcl-2 and bax were estimated using an immunohistochemical method. Bcl-2 was estimated in trophoblast, bax in decidua and trophoblast. Results: In a study group the mean value of bcl-2 in trophoblast was 37,04+/-10,51, in a control group the mean value was 65,74+/-6,97. The estimation of bax was done in trophoblast and decidua separately. In the group of FGR mean value of bax expression in trophoblast was 45,35+/-10,5. In decidua the mean bax expression value was 24,11+/-7,3. In controls in trophoblast the mean value was 12,53+/-7,54, in decidua the mean expression of bax was 6,63+/-2,24. Conclusion: 1. Apoptosis in trophoblast is lower in normal pregnancy than in FGR. 2. Increased expression of pro-apoptotic proteins in placenta might be one of the reason for FGR development.
Get Citation

Keywords

apoptosis, BAX, Bcl-2, Fetal Growth Retardation - physiopathology, Pregnancy Complications - pathology, Placenta - pathology, Trophoblasts - pathology

About this article
Title

The evaluation of selected indices of apoptosis in placentas from pregnancies complicated by fetal growth restriction

Journal

Ginekologia Polska

Issue

Vol 78, No 7 (2007)

Bibliographic record

Ginekol Pol 2007;78(7).

Keywords

apoptosis
BAX
Bcl-2
Fetal Growth Retardation - physiopathology
Pregnancy Complications - pathology
Placenta - pathology
Trophoblasts - pathology

Authors

Agata Karowicz-Bilińska
Anita Szczerba
Urszula Kowalska-Koprek
Agnieszka Nawrocka-Kunecka

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl